Northeastern University Patent Portfolio Statistics

tip_user1

Northeastern University

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Northeastern University look like?

Assignee Art Units
Total Applications: 916 2,049,590
Granted Patents: 443 1,197,140
Grant Index 69.76% ↓ 72.79%
Abandoned/Rejected Applications: 192 (30.24%) 447,401 (27.21%)
In-Process Applications: 275 405,049
Average Grant Time: 2.85 Years ↑ 2.65 Years
Average Office Actions: 1.55 ↑ 1.53

Which Technology Area Northeastern University is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 70
1795 – 17
1797 Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry 15
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 13
1626 Organic Chemistry 11

How many patents are Northeastern University filing every year?

Year Total Applications Predicted
2022 0* 86
2021 58* 85
2020 74 101
2019 64 64
2018 63 –
2017 67 –
2016 70 –
2015 69 –
2014 46 –
2013 36 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Northeastern University in USPTO?

Publication number: US20220238900A1
Application number: 17/613,591

Abstract:
Redox flow batteries that utilize indigo carmine and derivatives thereof as electrolytes are disclosed.

Publication date: –
Applicant: Northeastern University
Inventors: Hongli Zhu

Publication number: US20220212192A1
Application number: 17/613,138

Abstract:
Microfluidic devices and methods are provided for high-throughput generation, culturing, and analysis of cell spheroids, with subsequent isolation of selected cell spheroids for further analysis or isolation and expansion of cells from the spheroids. Any desired types of cells and matrices can be combined to form the cell spheroids and used to screen drugs and immunotherapy agents or methods, including in a personalized medicine format. Cell spheroids also can be cultivated and analyzed under hypoxic conditions. A particular advantage of the technology is the ability to isolate, enrich, and/or expand cells identified as having, or induced to have, desirable properties, such as immune cells that can be produced ex vivo and returned to the patient to combat a tumor or pathogen in vivo.

Publication date: –
Applicant: Northeastern University
Inventors: Konry Tania

Publication number: US20220218741A1
Application number: 17/613,157

Abstract:
Human dermal fibroblasts (HDF) and melanoma (MEL) cells are used herein for synthesis of metal nanoparticles. For example, synthesis of nanoparticles of gold (Au), palladium (Pd), platinum (Pt), and bimetallic formulations of gold-palladium (AuPd) and gold-platinum (AuPt) is demonstrated with HDF and MEL using a straightforward, eco-friendly and cost-effective approach. The nanostructures are purified and used in biomedical tests, which show selective behavior. The production of nanoparticles allows for stopping of the growth of cancer cells and the ability of new healthy cells to grow on top. The production of nanoparticles with the cells allows for an environmental-resistance behavior within the cells, showing the ability to stand for extreme environmental conditions.

Publication date: –
Applicant: Northeastern University
Inventors: J Thomas Webster

How are Northeastern University’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/613,591 All Natural Redox Flow Battery Utilizing Indigo Carmine And Derivatives Thereof Docketed New Case – Ready for Examination OPAP Central, Docket
17/613,138 Microfluidic Device For High-Throughput Screening Of Tumor Cell Adhesion And Motility Docketed New Case – Ready for Examination OPAP Central, Docket
17/613,157 Cell-Mediated Synthesis Of Noble Metal Oxide Nanoparticles And Biomedical Applications Thereof Docketed New Case – Ready for Examination OPAP Central, Docket
17/612,713 Carbene Mass Tagging Docketed New Case – Ready for Examination OPAP Central, Docket
17/453,941 Molecularly-Imprinted Electrochemical Sensors – OPAP Central, Docket